Compare AVTX & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | FLYE |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.6M | 2.7M |
| IPO Year | 2015 | 2024 |
| Metric | AVTX | FLYE |
|---|---|---|
| Price | $15.06 | $1.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | 953.5K | ★ 3.4M |
| Earning Date | 05-08-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | 61.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,813,137.00 | $19,063,357.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $12.41 | $0.48 |
| 52 Week High | $24.27 | $21.80 |
| Indicator | AVTX | FLYE |
|---|---|---|
| Relative Strength Index (RSI) | 32.60 | 41.19 |
| Support Level | $12.98 | $1.32 |
| Resistance Level | $15.27 | $1.92 |
| Average True Range (ATR) | 0.93 | 0.21 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 11.81 | 19.82 |
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Fly-E Group Inc is principally engaged in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. The Company encourages the adoption of eco-friendly transportation for active lifestyles.